Alabi Adewumi Olabimpe, Alabi Adegboyega Sunday, Sowunmi Anthonia Chima, Ololade Kehinde O, Adegboyega Bolanle Comfort, Habeebu Muhammad Yaqub M, Fatiregun Omolara Amina, Akinsola Folasade Bolanle
Department of Radiation Biology, Radio-diagnosis and Radiotherapy, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.
Department of Ophthalmology, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.
J West Afr Coll Surg. 2023 Jan-Mar;13(1):1-5. doi: 10.4103/jwas.jwas_37_21. Epub 2023 Jan 18.
The aim of this study was to review the management of orbito-ocular malignancies in the Departments of Radiotherapy and Ophthalmology, Lagos University Teaching Hospital, between January 1997 and December 2011 in comparison to previous and recent studies globally.
This was a retrospective study of orbito-ocular malignancies seen at the Departments of Radiotherapy and Ophthalmology, Lagos University Teaching Hospital from 1997 to 2011. Case files and treatment cards were retrieved through the Medical Records department and the information required was extracted with the aid of a data extraction form.
A total of 98 cases with histologically confirmed orbito-ocular malignancies seen during the 15-year study period were analysed. Retinoblastoma (51 [52.0%]) was the most common orbito-ocular malignancies seen in children, whereas squamous cell carcinoma of the conjunctiva (25 [25.5%]) was the most common in adults. Seventeen (17%) patients had a combination of radiotherapy, surgery, and chemotherapy. Thirty (33%) had enucleation, whereas 33 (36%) had exenteration. Thirty-six patients had chemotherapy, whereas 44 patients benefited from radiotherapy, and radical treatment was offered to 24 patients. Total radical treatment dose was 35-65 Gy in 20-35 fractions over 4-7 weeks. Most of the patients (84 [85.7%]) were lost to follow up. Five (5.1%) died from disease progression and four (4.1%) are still alive and on regular follow-up.
This study showed that the use of multimodality treatment was implemented but did not improve survival because the majority of patients presented late. The need for a collaborative effort in early detection and prompt referral for treatment of cancer cases cannot be overemphasised.
本研究旨在回顾1997年1月至2011年12月期间拉各斯大学教学医院放疗科和眼科对眼眶-眼部恶性肿瘤的管理情况,并与全球以往及近期的研究进行比较。
这是一项对1997年至2011年期间在拉各斯大学教学医院放疗科和眼科就诊的眼眶-眼部恶性肿瘤患者进行的回顾性研究。通过病历科检索病例档案和治疗卡,并借助数据提取表提取所需信息。
对15年研究期间组织学确诊的98例眼眶-眼部恶性肿瘤病例进行了分析。视网膜母细胞瘤(51例[52.0%])是儿童中最常见的眼眶-眼部恶性肿瘤,而结膜鳞状细胞癌(25例[25.5%])是成人中最常见的。17例(17%)患者接受了放疗、手术和化疗联合治疗。30例(33%)患者进行了眼球摘除术,33例(36%)进行了眶内容剜除术。36例患者接受了化疗,44例患者接受了放疗,24例患者接受了根治性治疗。根治性治疗总剂量为35 - 65 Gy,分20 - 35次,在4 - 7周内完成。大多数患者(84例[85.7%])失访。5例(5.1%)死于疾病进展,4例(4.1%)仍存活并定期接受随访。
本研究表明,多模式治疗方法已得到应用,但由于大多数患者就诊时已处于晚期,生存率并未得到改善。早期发现并及时转诊癌症病例进行治疗,迫切需要各方共同努力。